Study Shows InControl Medical Leads Market for In-Home Devices for Treating Urinary Incontinence; Sales Reach 100K Units

InControl Medical is pleased to announce the results of an independent
research study concluding that the Company is the market leader for
in-home devices for treating urinary incontinence. At the same time, the
Company is also announcing a milestone: As of June, 100,000 units of
ApexM, its flagship over-the-counter product for urinary incontinence in
women, have been sold.

Regarding the research report, Herschel (Buzz) Peddicord, CEO, says,
“This is an independent report done by an independent research
organization, and the analysis is spot on.” The report by Transparency
Market Research states, “lnControl
Medical is the market leader in electrical stimulation devices for
treatment of all the types of urinary incontinence, both in males and
females.” In fact, no one else is FDA-cleared for treatment of all types
of urinary incontinence in women. Over-the-counter electrical
stimulation devices ApexM
and Apex,
and prescription lnTone
products, are being increasingly adopted in the U.S., the report states.
The report also clearly shows a market trend moving away from catheters
and toward electrical stimulation devices, which are expected to reach a
market value of $849.9 million by 2025.

There are three types of incontinence – stress, urge and mixed. Numerous
scientific studies and clinical
reviews have found pelvic floor electrical stimulation to be a safe
and effective therapy for the treatment of all three types of
incontinence. InControl Medical offers a range of both over-the-counter
and prescription products to help both women and men resolve this
problem. In 2015, InControl Medical launched the first and only
over-the-counter, FDA-cleared and patented, non-invasive, electrical
stimulation device for women, ApexM.

“In April we announced a year-over-year 191% first quarter increase in
sales, with 90,000 units having been sold so far,” says Herschel
Peddicord. “Today we’re announcing that through June we’ve now sold
100,000 units. We’re not that surprised, and the results of the research
study are clearly borne out by the numbers. This is a highly effective
product that is improving the lives of women and men throughout the
country, and the success stories from both women and medical
professionals keep coming in. New products we’re developing this summer
will do even more.”

Located in Brookfield, Wisconsin, InControl Medical manufactures all
its products in the United States. An ISO 13485 certified facility for
quality manufacturing, InControl Medical meets or exceeds all federal
and state regulations regarding the sale of medical devices in the
United States, Canada and the European Union.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180711005560/en/

Leave a Comment